Special Sessions

Industrial Session

Co-sponsored by Pfizer, Inc.

Monday, July 24 & Tuesday, July 25
This special session is back by popular demand. Join Co-chairs Ted Broman (Vivus, Inc., U.S.A.) and Susan Cady (Intervet, Inc., U.S.A.) and attend these sure to be standing room only sessions. The featured speakers and their topics are:

Mimoun Ayoub, Genzyme Pharmaceuticals, Switzerland - Peptide Drugs: Design, Development and Manufacture
C. Theodore Broman, Vivus, Inc., U.S.A. - Project Management of Controlled Release Product Development Using Leadership, Principles and Tools to Deliver Value
John Gibson, Durect Corporation, U.S.A. - Biodegradable Polyester Excipients for Controlled Release Products: Synthesis, Properties, and Regulatory Considerations
Michael Hudson, Brookwood Pharmaceuticals, U.S.A. - Scaleup: Development to Commercialization
Michael Humphrey, Pfizer Global Research and Development, U.K. - Development Partnerships/Alliances
Peter Klusmann, Hoffmann-Eitle, Germany - IP/Legal
Joerg Kreuter, JW Goethe University, Germany - Nanoparticles as Drug Delivery Systems
Claire Madden-Smith, Molecular Profiles Ltd, U.K. - Analytical Aspects of Product Development
Franklin Okumu, Durect Corporation, U.S.A. - Protein Formulation for Injectable Drug Delivery Systems
Dody Reimer, Northern Lipids Inc., Canada - Liposome Formulations of Sparingly Soluble Compounds
Terrence Scott, EPIC Therapeutics, U.S.A. - PROMAXX Microsphere Drug Delivery Technology
Mary Sticklemeyer, Eli Lilly and Company, U.S.A. - Controlled Release Parenterals: Regulatory Considerations from an Industrial Perspective
Avinash G. Thombre, Pfizer, Inc., U.S.A. - Oral Controlled Release Fixed Dose Combination Products
Thomas R. Tice, Brookwood Pharmaceuticals, U.S.A. - Selecting the Right Formulation Technology

Capsugel/Pfizer Special Session

Tuesday, July 25
Session Chair Vladimir Torchilin invites you to hear four outstanding students present their award winning abstracts on innovative aspects of oral drug delivery and absorption during this Capsugel/Pfizer Special Session. The Capsugel/Pfizer Special Session's Invited Speakers and their topics are as follows:

David Brayden, University College Dublin, Ireland - Peyer's Patch M Cells: Delivery and Targeting Oral Vaccines
John Smart, University of Brighton, U.K. - Buccal Drug Delivery
Istvan Toth, University of Queensland, Australia - Liposaccharides in Peptide and Gene and Vaccine Delivery
At the conclusion of the session, witness Jan Vertommen of Pfizer, Inc., announce the Capsugel/Pfizer Special Session Grand Prize winning student.

Eurand Special Session

Wednesday, July 26
The Eurand Novel Approaches Award is recognized as a premiere industry award and designed to encourage, recognize, and reward innovative approaches in oral drug delivery. During this Eurand Special Session, three Eurand Novel Approaches Honorees, along with the 2006 Eurand Career Achievement in Commercialized Technology of Oral Drug Delivery Award Recipient, will present their research. The Novel Approaches Grand Prize Winner will be selected during the Eurand Special Session and announced by Stephen Perrett of Eurand.

Banner's Industrial Insights Luncheon

Monday, July 24
Watch for more details on this first ever, by invitation only, luncheon hosted by Banner.